NOVOCURE LTD

NVCR · NASDAQ

Updated at 2026-10-13 14:35:20

$14.47-1.69%
Today's High
$14.76
Today’s Low
$14.39
NOVOCURE LTD (NVCR) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$14.54
Previous Close
$14.72
Volume
781.97K
Market Cap
$1.71B
P/E Ratio
--
EPS
$-1.30

Previous Day Range

$14.26$14.76

52-Week Range

$9.82$21.45

Company Overview

Sector
HEALTHCARE
Industry
Health Care
Sub-industry
MEDICAL DEVICES
Headquarters
NEUHOFSTRASSE 21, BAAR, SWITZERLAND, 6340
Country
JE
Listing Date
2015-10-01
Fiscal Year End
December
Shares Outstanding
116.45M
CIK
0001645113

NovoCure Limited, an oncology company, is engaged in the development, manufacture and marketing of Optune for the treatment of a variety of solid tumors. The company is headquartered in Saint Helier, Jersey.

Financial Metrics

Revenue

2026-06-30

$183.58M

2026-03-31

$174.05M

2025-12-31

$174.35M

2025-09-30

$167.2M

Operating Expenses

2026-06-30

$153.04M

2026-03-31

$202.54M

2025-12-31

$172.58M

2025-09-30

$158.49M

Net Income

2026-06-30

-$15.65M

2026-03-31

-$71.13M

2025-12-31

-$24.49M

2025-09-30

-$37.27M

Net Profit Margin

2026-06-30

-8.52%

2026-03-31

-40.87%

2025-12-31

-14.05%

2025-09-30

-22.29%

Earnings Per Share

2026-06-30

$-0.13

2026-03-31

$-0.62

2025-12-31

$-0.22

2025-09-30

$-0.33

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$6.25M

2026-03-31

-$63.29M

2025-12-31

-$36.73M

2025-09-30

-$26.35M

Effective Tax Rate

2026-06-30

-25.74%

2026-03-31

-2.71%

2025-12-31

40.17%

2025-09-30

-24.14%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.